6-MAPB Stats & Data
NPS DataHub
MW189.26
FormulaC12H15NO
CAS1354631-79-0
IUPAC1-(benzofuran-6-yl)-N-methylpropan-2-amine
SMILES
CNC(C)Cc1ccc2ccoc2c1InChIKey
QLAAURQYEAEHBO-UHFFFAOYSA-N
Chemical Class
Substituted benzofuran
Psychoactive Class
Psychedelic / Stimulant
Effect Profile
Curated + 1 Reports
Psychedelic
2.8
Mild visuals with low body load and headspace
Visual Intensity×3
4
Headspace Depth×3
1
Auditory Effects×1
0
Body Load / Somatic Effects×1
3
Empathogen
4.1
Moderate sensory enhancement and stimulation with mild euphoria, low empathy
Empathy / Social Openness×3
2
Euphoria / Mood Elevation×2
5
Stimulation×1
6
Sensory Enhancement×1
7
Stimulant
4.0
Mild stimulation and euphoria with moderate anxiety/jitters, low focus
Stimulation / Energy×3
5
Euphoria / Mood Lift×2
5
Focus / Productivity×2
2
Anxiety / Jitters×1
7
Based on reports from:
Duration Timeline
Bluelight
Onset
Comeup
Peak
Offset
After Effects
Insufflated
Total: 5-10 hours
Oral
Total: 5-10 hours
Tolerance & Pharmacokinetics
drugs.wikiNo tolerance chart. No study has measured how long tolerance to it lasts, so this page shows what is known instead of a curve.
Nothing has been published on tolerance to 6-MAPB, and no reference source gives a figure; research is limited to cell and rat studies. In rats and in human liver preparations it is partly converted to 6-APB.
Sources: Brandt et al. 2020 · Welter et al. 2015
Cross-Tolerances
MDMA
MDA
Experience Report Analysis
Erowid
1
Reports
2014–2014
Date Range
1
With Age Data
Demographics
Gender Distribution
Too few reports for a chart: gender is known from 1 report, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?
- Male 1 of 1